SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-017568
Filing Date
2019-05-09
Accepted
2019-05-09 07:13:29
Documents
64
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q urgn-10q_20190331.htm 10-Q 1632844
2 EX-31.1 urgn-ex311_9.htm EX-31.1 19364
3 EX-31.2 urgn-ex312_8.htm EX-31.2 19382
4 EX-32.1 urgn-ex321_7.htm EX-32.1 9503
5 EX-32.2 urgn-ex322_6.htm EX-32.2 9635
  Complete submission text file 0001564590-19-017568.txt   5003564

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT urgn-20190331.xml EX-101.INS 908396
7 XBRL TAXONOMY EXTENSION SCHEMA urgn-20190331.xsd EX-101.SCH 43696
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE urgn-20190331_cal.xml EX-101.CAL 42065
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE urgn-20190331_def.xml EX-101.DEF 100827
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE urgn-20190331_lab.xml EX-101.LAB 303435
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE urgn-20190331_pre.xml EX-101.PRE 227038
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Filer) CIK: 0001668243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38079 | Film No.: 19808758
SIC: 2834 Pharmaceutical Preparations